-
-
First Patient Dosed of Phase 2 Clinical Trial of Serplulimab in Combination with Innovative Anti-LAG-3 mAb for the Treatment of Metastatic Colorectal Cancer Patients
2023-06-15
Shanghai, China, June 15th, 2023 - Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first patient has been dosed in a phase 2 clinical trial (NCT05584137) of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with HLX26, an innovative anti-LAG-3 mAb for the trea
-
-
Fosun Ranks 5th on China ESG (Corporate Social Responsibility) Release’s List of China’s Top 100 ESG Listed Companies
2023-06-14
On the afternoon of 13 June 2023, the Financial Program Center of China Media Group (CMG), together with the State-owned Assets Supervision and Administration Commission of the State Council (SASAC), the All-China Federation of Industry and Commerce (ACFIC), the Institute of Economics of the Chinese Academy of Social Sciences (CASS), the China Enterprise R
-
-
Henlius Shines for Five Consecutive Years at BIO International Convention
2023-06-12
-
-
Wolves announce Partnership with Shede Spirits
2023-06-09
The new partnership will see Shede’s Tuopai brand become the club’s Official Baijiu Partner for the 2023/24 season.Tuopai is one of the best known and well renowned liquor brands in China.With sales of over five billion bottles in the country, Tuopai has left a profound impression on generations of Chinese people, and the partnership with Wolves will further grow the b
-
-
Investor Open Day: Fosun Implements Business Streamlining and Resilience Building Strategy, Focusing on Core Businesses to Bring New Vitality
2023-06-08
-
-
Fosun Pharma and IFC Partner to Improve Access to High Quality Medicines in Africa
2023-06-06
(Abidjan, Côte d’Ivoire, June 6, 2023) To support stronger healthcare delivery and outcomes in West Africa,Shanghai Fosun Pharmaceutical (Group) Co., Ltd.(Fosun Pharma or the Company, stock code: 600196.SH; 02196.HK) today announced a deepening partnership with IFC to help the company build a pharmaceutical production facility and distributio
-
-
2023 Shanghai Night Festival Opens at the Bund Finance Center
2023-06-03
On 3 June 2023, the opening ceremony for the 4th Shanghai Night Festival themed “Sleepless in Shanghai” was held at the Bund Finance Center (BFC).
-
-
515 Fosun Family Day Sets Off Consumption Boom With Cumulative Sales of Nearly RMB10 Billion
2023-06-02
Since the launch of Shanghai’s 4th Double Five Shopping Festival, more than 1,000 promotion activities have been held successively in the month, setting off a consumption boom. As an essential part of the Double Five Shopping Festival, the 515 Fosun Family Day delivered stellar results with nearly 10 billion (RMB, same below) omni-channel sales, boosting consumption
-
-
Results from the Phase 3 Clinical Study of Novel Anti-PD-1 mAb Serplulimab for the First-line Treatment of ESCC Released at 2023 ASCO Annual Meeting
2023-06-02